Literature DB >> 5116056

Myocardial effects of indoramin hydrochloride, a new hypotensive agent.

D J Coltart, S J Meldrum, R B Royds.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5116056      PMCID: PMC1665764     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Autonomic blocking properties of Wy 21901.

Authors:  B J Alps; M Hill; E S Johnson; A B Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

2.  Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.

Authors:  B J Alps; E S Johnson; A B Wilson
Journal:  Br J Pharmacol       Date:  1970-09       Impact factor: 8.739

3.  Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents.

Authors:  W C Govier
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

  3 in total
  3 in total

1.  Cardiovascular effects of indoramin in man--a dose ranging study.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

2.  Effect of indoramin on human sperm motility.

Authors:  R B Verma; S M Abrams; P Turner
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

Review 3.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.